Pfizer acquisition of cancer drug company could advance oncology research

Published Online: Aug 23,2016 Laurie Toich, Assistant Editor Pfizer recently announced its plans to acquire Medivation, a biopharmaceutical company that develops molecules for oncology. Recent health insurer mergers could have deterred the $14 billion deal, but Pfizer and Medivation’s boards of directors approved the merger, and expect that shares will increase immediately, according to a press release from Pfizer. “The proposed …

Tulane University – Rebuilding a Research Powerhouse

Ahead of BioData World Congress we wanted to share some examples of where high-performance computing is having a real and meaningful impact on scientific research. Tulane University needed to create a new high-performance (HPC) infrastructure following the devastation of Hurricane Katrina. Technology from Intel and Dell brings an all-in-one cluster solution to Tulane, helping them to achieve extraordinary work across …

Download: Pharma-Payer Research Collaborations

At Evidence USA 2013, Rami Ben-Joseph, Head of Health Outcomes and Pharmacoeconomics, Purdue Pharma gave a presentation on “Pharma-Payer Research Collaborations” Download to learn: Healthcare paradigm shift Patients empowered by technology Payer research collaborations Stakeholder objectives Shared value via scientific dialogue and collaborative research Contributions Outcomes: Pharma Outcomes: Payer Download presentation Rami Ben- Joseph will be presentating at this year’s …

What impact will the Ebola outbreak have on drug development for other neglected tropical diseases?

The 2014 Ebola outbreak in West Africa has devastated communities, leaving over 1000 dead according to WHO. Although arguably largely unreported in mainstream media until it started spreading outside of Africa, there is now lots of action in the Ebola space from companies throughout the world. It is unfortunate that it has taken this long for Ebola to get so much …

Stem Cells USA is where industry experts like RXi Pharmaceuticals gather to network, learn from each other, and discuss the latest stem cell strategies and technology.

Making the case for investment in early stage biotech companies

Geert Cauwenbergh, President and Chief Executive Officer of RXi Pharmaceuticals, presented at the Stem Cells & Regenerative Medicine Congress in 2013. You can now download his presentation slides from the event, where he addressed making the case for investment in early stage biotech companies. Download the presentation now  Geert is a member of the board of directors of Ablynx NV …

The Stem Cells Regenerative Medicine Congress is where experts like Russell Marians of LABS Inc meet to network, learn from each other, and discuss the latest stem cells strategies and technology.

LABS Inc on ensuring successful scale-up manufacturing

We were glad to have Russell Marians, Senior Scientist and Manager of Molecular and Cellular Biology at LABS Inc., present at the Stem Cells & Regenerative Medicine Congress in 2013. You can now download his presentation slides and video from the event, where he addresses how a winning assay development strategy is critical to ensure successful scale-up manufacturing. Download the presentation …

Download Building Bridges from Research to Therapy

Thomas Fellner, PhD, MBA Director, Cell Therapy, Lonza joined us last year at the World Stem Cells & Regenerative Medicine Congress to present on ‘Building Bridges from Research to Therapy: Establishing a cGMPcompliant process for the generation of iPSCs.’ Download this presentation now to find out more about: Case Study: An Allogeneic iPSC-based Therapy for Parkinson’s Disease The Cost of …

BioPharma Mexico is where experts like AstraZeneca's Ajam Gautam meet to network, learn from each other, and discuss the latest biopharma strategies and technology.

AstraZeneca’s Ajay Gautam on Innovative R&D for Emerging Markets

We were glad to have Ajay Gautam, Executive Director and Head of Emerging Markets R&D at AstraZeneca, present at last year’s BioPharma Mexico. You can now download his slides from the event, where he addressed innovative R&D models for emerging markets under the main heading “How to grow the Mexican pharma industry”. View the presentation here Dr. Gautam has a …

We were glad to have the FDA share their stem cells and regenerative medicine expertise at Stem Cells USA.

The FDA on regulatory developments in stem cell, cell and gene therapies

Mohammad Heidaran, of the Office of Cellular, Tissue and Gene Therapies, CBER at the FDA, presented at the Stem Cells & Regenerative Medicine Congress in 2013. Enclosed are his presentation slides from the event, where he addresses clarifying aspects like potency assays, purity and identity assessment. You can now view the recording of his presentation alongside these slides, so that …